{"id":"W2162020809","doi":"10.1016/s2352-3026(15)00020-4","title":"90 Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study","year":2015,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Université de Nantes; Université de Bretagne Occidentale","keywords":"Radioimmunotherapy; Medicine; Tolerability; CD22; Refractory (planetary science); Internal medicine; Oncology; Nuclear medicine; Gastroenterology; Lymphoma; CD20; Adverse effect; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009791804,0.001292664,0.001919132,0.0003223827,0.0002800494,0.001048788,0.0007021078,0.001021328,0.001793824],"category_scores_gemma":[0.0005725891,0.0006246027,0.001035479,0.0003933185,0.0008902595,0.0008304541,0.0003640319,0.002937934,0.0008674424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008771067,"about_ca_system_score_gemma":0.0007453418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001300635,"about_ca_topic_score_gemma":0.001726876,"domain_scores_codex":[0.9996625,0.000142477,0.00001356434,0.00006366742,0.00002712492,0.00009061323],"domain_scores_gemma":[0.9997312,0.00004913286,0.00005300268,0.00003929808,0.00001423796,0.0001131004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6227437,0.05633318,0.01332644,0.0009961389,0.002847322,0.0009647859,0.001176548,0.007257425,0.08057687,0.0006486044,0.005398002,0.2077309],"study_design_scores_gemma":[0.4763495,0.4801664,0.02710318,0.0000514529,0.001279672,0.0008169108,0.0001859132,0.002070686,0.005730595,0.0003136816,0.005870239,0.00006172864],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971073,0.001156911,0.0002467191,0.0001943797,0.00004677748,0.0002949849,0.0002005816,0.00004897724,0.0007032795],"genre_scores_gemma":[0.9943373,0.001888757,0.0006382212,0.000491092,0.0000611514,0.0004680912,0.0005474905,0.00003974199,0.00152812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001919132,"threshold_uncertainty_score":0.006363928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04679705980917849,"score_gpt":0.3532113727698215,"score_spread":0.306414312960643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}